copper chelate comes up often in conversation and rarely with the context attached. Here we lay out the basics in order, then work through the practical considerations.
Updated 2025-12-04. Numbers and descriptions here follow the published literature rather than marketing material.
The compound was first isolated from human plasma in the 1970s by Loren Pickart, who later described copper-binding activity in liver and other tissues. Early reports focused on its presence in blood and its ability to carry copper between proteins. Commercial and cosmetic use of the term 'copper peptide' has since broadened, and labels rarely distinguish GHK-Cu from other copper-binding fragments. This naming overlap makes literature searching harder, because cosmetic ingredient lists, supplier catalogues and laboratory papers use different vocabularies for the same molecule.
GHK-Cu is the copper-binding complex formed by the tripeptide glycyl-L-histidyl-L-lysine and a copper(II) ion. The free peptide is usually written as GHK, and the complex is written as GHK-Cu or Cu-GHK. The sequence was identified in human plasma and later detected in saliva and urine. Its name comes from the single-letter codes of glycine, histidine and lysine. The complex is widely described as a naturally occurring carrier of copper in blood rather than as a free peptide with its own hormonal role.
The copper-binding activity of this sequence was described in the 1970s during studies of liver tissue and plasma factors. Early work identified the peptide as a component that influenced copper uptake by cells and that appeared in wound fluid. Later investigations examined its presence across species, reporting the same chain in human and animal samples. A decline in measured concentration with age became a recurring observation, although the underlying causes remain incompletely characterised.
Published studies describe the complex in several research contexts, including collagen synthesis, antioxidant behaviour, and wound repair models. Much of this work is conducted in cultured cells or in small animal systems, and the findings are frequently cited in reviews of copper peptides. Direct clinical evidence in humans is comparatively limited, and reported outcomes vary with formulation and study design. Whether free chain or metal-bound form was used is not always stated, a point that complicates comparison between reports.
| Property | Value | Notes |
|---|---|---|
| Sequence | Gly-His-Lys | Three amino acids; histidine supplies the main copper-binding nitrogen |
| Bound metal | Copper(II) | Coordination is described as square-planar around the metal centre |
| Appearance | Blue to violet solid | Colour originates from copper d-d electronic transitions |
| Solubility class | Freely soluble in water | Aqueous solutions are often slightly acidic |
| Common synonyms | Copper tripeptide, Cu-GHK | Ingredient lists may say only 'copper peptide' without giving the sequence |
Quality control for GHK-Cu relies on documentation and independent testing rather than a single accepted standard. A certificate of analysis may report peptide purity, copper content, residual solvents, water content, and microbial limits, but the underlying methods and acceptance criteria vary by supplier. Verification can include mass confirmation, amino acid analysis, and comparison with a reference standard when one is available. Open questions include how different copper-binding modes or peptide isomers affect measured activity and whether conventional purity assays capture those differences. Buyers of research-grade material typically need to request raw data rather than rely solely on a summary certificate.
Laboratory characterization of GHK-Cu typically combines separation, spectroscopic, and elemental techniques. Reverse-phase high-performance liquid chromatography is widely used to assess peptide purity, often with ultraviolet detection near the copper-related absorption band or with mass spectrometry for identity confirmation. Because the molecule contains copper, elemental methods such as inductively coupled plasma mass spectrometry or atomic absorption spectroscopy are used to quantify metal content and confirm stoichiometry. No single universal pharmacopeial monograph exists for GHK-Cu. Laboratories therefore validate their own methods, and reported purity values depend on the chosen assay and calibration standards.
Published work on GHK-Cu concentrates largely on cell culture systems rather than whole organisms. Frequently used endpoints include collagen synthesis, expression of matrix metalloproteinases, and migration of fibroblasts. Some reports describe antioxidant behavior, while others stress delivery of copper into cells. These mechanisms are proposed rather than demonstrated, and the relative weight of each pathway is unclear. Human trials are few and generally small, so laboratory findings should not be read as confirmed clinical results.
GHK-Cu is a coordination complex formed between the tripeptide glycyl-L-histidyl-L-lysine and a copper(II) ion. The peptide backbone consists of glycine, histidine, and lysine joined in that order. Copper is held through the imidazole nitrogen of histidine and the alpha-amino group at the N-terminus, which together produce a square-planar arrangement around the metal center. The solid appears blue to violet, a color that originates from d-d electronic transitions within the copper coordination sphere. The complex is indexed under CAS number 89030-95-5.
Endogenous GHK occurs in blood plasma, saliva, and urine, and reported plasma concentrations decline with age in several studies. Researchers have proposed that the peptide acts as a copper carrier that delivers the metal to cells and to sites of injury. That transport role is a hypothesis supported by binding measurements and tissue-distribution data rather than a settled mechanism, and the peptide is generally described as a minor contributor to total plasma copper transport. Values reported in wound fluid and certain tissue extracts are higher than in circulating plasma.
The sequence carries three residues in the order glycine, histidine, lysine, which places a small, flexible chain around a single metal centre. Compared with larger copper-binding proteins, the complex is compact and its coordination chemistry can be reproduced with synthetic peptide in a laboratory. Published structural work agrees on the nitrogen donor set but differs in the exact geometry assigned under some conditions, so the arrangement is best treated as well characterised in outline rather than fixed in every detail.
GHK-Cu is a coordination complex formed between the tripeptide glycyl-L-histidyl-L-lysine and a copper(II) ion. The peptide was isolated from human plasma in the early 1970s by Loren Pickart, who observed that a plasma fraction from young donors stimulated growth in cultured liver cells. The copper-bound form is abbreviated GHK-Cu, while the metal-free peptide is written simply as GHK. In the research literature the complex also appears as copper tripeptide-1 and as glycyl-histidyl-lysine copper complex.
Stability depends on temperature, light exposure, moisture, and the presence of oxidizing or reducing agents. Solid material held dry and protected from light is generally more stable than aqueous solutions, which can undergo gradual degradation. Recommended storage in much of the literature is a freezer at around minus twenty degrees Celsius for long-term retention, with working aliquots kept cold and shielded from light. Repeated freeze-thaw cycles and alkaline pH are commonly noted as factors that accelerate loss of the intact complex, though exact degradation rates vary.
Analytical confirmation usually combines a separation method with a copper-specific measurement. Liquid chromatography or mass spectrometry establishes peptide identity and purity, while an elemental measurement quantifies the metal content. A frequent misconception is that any blue solution contains an intact copper peptide complex; color alone does not confirm structure, because free copper salts and degraded mixtures can also appear colored. Literature on efficacy is mixed, with in vitro findings often more dramatic than human evidence, and reviews note small sample sizes and short follow-up. Open questions include optimal concentration, skin penetration, and long-term effects.
Proposed mechanisms for copper peptide activity center on delivery of copper ions to cells and on peptide fragments acting as signaling molecules. Copper is a cofactor for enzymes involved in collagen cross-linking and antioxidant defense, and the peptide may improve its availability at target sites. Separately, the tripeptide and its breakdown products have been reported to influence gene expression in cultured fibroblasts. Much of this evidence comes from laboratory cell cultures and animal models rather than controlled human trials. The relative contribution of the copper ion and the peptide sequence is therefore not fully settled.
Without the first layer of "capture" antibody, any proteins in the sample (including serum proteins) may competitively adsorb to the plate surface, lowering the quantity of antigen immobilized. Use of the purified specific antibody to attach the antigen to the plastic eliminates a need to purify the antigen from complicated mixtures before the measurement, simplifying the assay, and increasing the specificity and the sensitivity of the assay. Therefore, a sandwich ELISA used for research often needs validation, to reduce the risk of false positive results.
== Industry applications == The liquid chromatography marketplace is incredibly diverse. Five to ten firms are consistently market leaders, yet nearly half of the market is made up of small, fragmented companies. This section of the report will focus on the roles that a few companies have had in bringing monolith column technologies to the commercial market. In 1998, start-up biotechnology company BIA Separations of Ljubljana, Slovenia, came into being. The technology was originally developed by Tatiana Tennikova and Frantisek Svec during a collaboration between their respective institutes. The patent for these columns was acquired by BIA Separations and Ales Podgornik and Milos Barut developed the first commercially available monolith column in the form of a short disc encapsulated in a plastic housing. Trademarked CIM, BIA Separations has since introduced full lines of reversed-phase, normal-phase, ion-exchange, and affinity polymeric monoliths. Ales Podgornik and Janez Jancar then went on to develop large scale tube monolithic columns for industrial use. The largest column currently available is 8L. In May 2008, LC instrumentation powerhouse Agilent technologies agreed to market BIA Separations’ analytical columns based on monolith technology. Agilent's commercialized the columns with strong and weak ion exchange phases and Protein A in September 2008 when they unveiled their new Bio-Monolith product line at the BioProcess International conference.
=== X-ray crystal structure determination === The first X-ray crystal structures of tetrahedral intermediates were obtained in 1973 from bovine trypsin crystallized with bovine pancreatic trypsin inhibitor, and in 1974 from porcine trypsin crystallized with soybean trypsin inhibitor. In both cases the tetrahedral intermediate is stabilized in the active sites of enzymes, which have evolved to stabilize the transition state of peptide hydrolysis. Some insight into the structure of tetrahedral intermediate can be obtained from the crystal structure of N-brosylmitomycin A, crystallized in 1967. The tetrahedral carbon C17 forms a 136.54 pm bond with O3, which is shorter than C8-O3 bond (142.31 pm). In contrast, C17-N2 bond (149.06 pm) is longer than N1-C1 bond (148.75 pm) and N1-C11 bond (147.85 pm) due to donation of O3 lone pair into σ* orbital of C17-N2. This model however is forced into tetracyclic sceleton, and tetrahedral O3 is methylated which makes it a poor model overall.
==== General election ==== On July 25, 2000, Bush surprised some observers when he selected Dick Cheney – a former White House chief of staff, U.S. representative, and secretary of defense – to be his running mate. At the time, Cheney was serving as head of Bush's vice presidential search committee. Soon after at the 2000 Republican National Convention, Bush and Cheney were officially nominated by the Republican Party. Bush continued to campaign across the country and touted his record as Governor of Texas. During his campaign, Bush criticized his Democratic opponent, incumbent vice president Al Gore, over gun control and taxation. When the election returns were tallied on November 7, Bush had won 29 states, including Florida. The closeness of the Florida outcome led to a recount. The initial recount also went to Bush, but the outcome was tied up in lower courts for a month until eventually reaching the U.S. Supreme Court. On December 9, in the controversial Bush v. Gore ruling, the Court reversed a Florida Supreme Court decision that had ordered a third count, and stopped an ordered statewide hand recount based on the argument that the use of different standards among Florida's counties violated the Equal Protection Clause of the Fourteenth Amendment. The machine recount showed that Bush had won the Florida vote by a margin of 537 votes out of six million casts.
Sources: en.wikipedia.org
== Explanation of anomalous behaviour == Water is a polar molecule, where the centers of positive and negative charge are separated; so molecules will align with an electric field. The extensive hydrogen bonded network in water tends to oppose this alignment, and the degree of alignment is measured by the relative permittivity. Water has a high relative permittivity of about 80 at room temperature; because polarity shifts are rapidly transmitted through shifts in orientation of the linked hydrogen bonds. This allows water to dissolve salts, as the attractive electric field between ions is reduced by about 80–fold. Thermal motion of the molecules disrupts the hydrogen bonding network as temperature increases; so relative permittivity decreases with temperature to about 7 at the critical temperature. At 205 °C the relative permittivity falls to 33, the same as methanol at room temperature. Thus water behaves like a water–methanol mixture between 100 °C and 200 °C. Disruption of extended hydrogen bonding allows molecules to move more freely (viscosity, diffusion and surface tension effects), and extra energy must be supplied to break the bonds (increased heat capacity).
== History == With the capture of Óscar Orlando Nava Valencia in October 2009 and the death of Ignacio Coronel Villarreal, of the Sinaloa Cartel in 29 July 2010, a power vacuum emerged and the Milenio Cartel (then loyal to the Sinaloa Cartel) broke into smaller factions. The most notable were the Jalisco New Generation Cartel (CJNG) headed by Nemesio Oseguera Cervantes "El Mencho" (who suspected the Sinaloa cartel had betrayed its leaders) and La Resistencia headed by Ramiro Pozos "El Molca" who switched alliances to form a brief alliance with Los Zetas (La Resistencia was founded by Sinaloa to counter Los Zetas), and started a turf war for control of the region. Some members of the Milenio Cartel, then a Sinaloa Cartel branch, who splintered and formed the CJNG were Nemesio Oseguera Cervantes (El Mencho), Érick Valencia Salazar (El 85) and Martín Arzola Ortega (El 53). With this split, a turf war against La Resistencia, headed by Ramiro Pozos (El Molca), and Los Zetas for the control of the region started. Emilio Alejandro Pulido Saldaña, better known as "El Tiburón", was considered to be a co-founder as well.
== Personal life == Woolley married bacteriologist Janet Ruth McCarter in 1945. Woolley had Diabetes mellitus type 1 from childhood, and in 1923 was among the first children to receive insulin to treat the condition. He nonetheless experienced blindness as a complication of his diabetes, and was completely blind from age 25 until his death from a heart attack at age 52, while hiking in Cuzco, Peru.
There is insufficient evidence for the COVID-19 Treatment Guidelines Panel (the Panel) to recommend either for or against the use of vitamin C for the treatment of COVID-19 in nonhospitalized patients. There is insufficient evidence for the Panel to recommend either for or against the use of vitamin C for the treatment of COVID-19 in hospitalized patients. For people hospitalized with severe COVID-19 there are reports of a significant reduction in the risk of all-cause, in-hospital mortality with the administration of vitamin C relative to no vitamin C. There were no significant differences in ventilation incidence, hospitalization duration or length of intensive care unit stay between the two groups. The majority of the trials incorporated into these meta-analyses used intravenous administration of the vitamin. Acute kidney injury was lower in people treated with vitamin C treatment. There were no differences in the frequency of other adverse events due to the vitamin. The conclusion was that further large-scale studies are needed to affirm its mortality benefits before issuing updated guidelines and recommendations.
=== Pharmacogenetics === Since doxepin is mainly metabolized by CYP2D6, CYP2C9, and CYP2C19, genetic variations within the genes coding for these enzymes can affect its metabolism, leading to changes in the concentrations of the drug in the body. Increased concentrations of doxepin may increase the risk for side effects, including anticholinergic and nervous system adverse effects, while decreased concentrations may reduce the drug's efficacy. Individuals can be categorized into different types of cytochrome P450 metabolizers depending on which genetic variations they carry. These metabolizer types include poor, intermediate, extensive, and ultrarapid metabolizers. Most people are extensive metabolizers, and have "normal" metabolism of doxepin. Poor and intermediate metabolizers have reduced metabolism of the drug as compared to extensive metabolizers; patients with these metabolizer types may have an increased probability of experiencing side effects. Ultrarapid metabolizers break down doxepin much faster than extensive metabolizers; patients with this metabolizer type may have a greater chance of experiencing pharmacological failure. A study assessed the metabolism of a single 75 mg oral dose of doxepin in healthy volunteers with genetic polymorphisms in CYP2D6, CYP2C9, and CYP2C19 enzymes. In CYP2D6 extensive, intermediate, and poor metabolizers, the mean clearance rates of (E)-doxepin were 406, 247, and 127 L/hour, respectively (~3-fold difference between extensive and poor).
Sources: en.wikipedia.org
=== Feud with the House and Marcos-Duterte rift === A rift between the Duterte and Marcos families had begun under House Speaker Martin Romualdez' leadership. In the House of Representatives, unconfirmed reports of Deputy House Speaker Gloria-Macapagal Arroyo allegedly attempting to unseat Romualdez as House Speaker circulated. Despite Arroyo dismissing the accusations, Arroyo was later demoted by the House from her senior deputy Speaker position. Duterte's daughter, Vice President and Education Secretary Sara, subsequently resigned from the Romualdez-led Lakas-CMD and, in a veiled reference to Romualdez, called him a "tambaloslos" (A term that can be interpreted as a joke or as an insult, depending on context). In October 2023, Sara requested Congress for the allocation of confidential funds for the office of the vice president (OVP) and the education department which can be used for the Reserve Officers' Training Corps program. Her requests came under intense scrutiny by the Senate and the House, which was dominated by Romualdez's allies. Congress ultimately rejected her appeals while swiftly approving the confidential funds of the Office of the President; Sara eventually dropped her requests, reasoning that the move was being "divisive". In the aftermath of events, Duterte criticized the House for denying his daughter's confidential funds; alleging a collusion between Romualdez and the left-wing Makabayan bloc, he demanded an audit of the House under Romualdez.
On the other side, synthetic data can be deployed to train machine learning models while preserving user privacy. The approach is not limited to text generation; image generation has been employed to train computer vision models.
The next step is to form 1,2,3-Benzotriazin-4(3H)-one-14C (compound 4). In water dissolved sodium nitrite is added to anthranilamide and hydrochloric acid in ice water. Because this is a diazotization reaction, the product is pale-yellow again. After this the pH is adjusted to 8,5. This causes the ring closure to form 1,2,3-Benzotriazin-4(3H)-one-14C. This results in a sodium salt slurry that can be treated with hydrochloric acid, what lowers the pH down to 2 till 4. The 1,2,3-Benzotriazin-4(3H)-one-14C is collected, washed and dried. In the following step 1,2,3-Benzotriazin-4-(3-chloromethyl)-one-14C has to be formed. Therefore, 1,2,3-Benzotriazin-4(3H)-one-14C and paraformaldehyde are added to ethylene dichloride and heated to 40 °C. Then thionyl chloride is added and the whole solvent is further heated to 65 °C. After four hours of heating the solution is cooled down to room temperature. Water is added and the solution is neutralized. The ethylene dichloride layer is removed and put together with the result of the washed aqueous layer. The solvent was filtered and dried. The last step is the actual synthesis of Azinphos methyl. Ethylene dichloride is added to the compound resulting from the fifth step, 1,2,3-Benzotriazin-4-(3-chloromethyl)-one-14C. This mixture is heated to 50 °C and sodium bicarbonate and O,O-dimethyl phosphorodithioate sodium salt in water are added. The ethylene dichloride layer is removed, reextracted with ethylene dichloride and purified by filtration. The pure filtrate is dried.
In 1996, an outbreak of measles, cholera, and bacterial meningitis occurred in Nigeria. Pfizer representatives and personnel from a contract research organization (CRO) traveled to Kano to set up a clinical trial and administer an experimental antibiotic, trovafloxacin, to approximately 200 children. Tests in animals showed that Trovan had life-threatening side effects, including joint disease, abnormal cartilage growth, liver damage, and a degenerative bone condition. Pfizer's representatives did not alert the parents or patients about the serious risks involved, or tell them about an effective conventional treatment that Doctors without Borders was providing at the same site. Local Kano officials reported that more than fifty children died in the experiment, while many others developed mental and physical deformities such as blindness, deafness, paralysis, and brain damage. The nature and frequency of both fatalities and other adverse outcomes were similar to those historically found among pediatric patients treated for meningitis in sub-Saharan Africa. In 2001, families of the children, as well as the governments of Kano and Nigeria, filed lawsuits regarding the treatment.
Among the many varieties of microorganisms, relatively few cause disease in otherwise healthy individuals. Infectious disease results from the interplay between those few pathogens and the defenses of the hosts they infect. The appearance and severity of disease resulting from any pathogen depend upon the ability of that pathogen to damage the host as well as the ability of the host to resist the pathogen. However, a host's immune system can also cause damage to the host itself in an attempt to control the infection. Clinicians, therefore, classify infectious microorganisms or microbes according to the status of host defenses – either as primary pathogens or as opportunistic pathogens.
Sources: en.wikipedia.org
The letters GHK are the one-letter codes for glycine, histidine and lysine, the three amino acids in the peptide. The suffix Cu indicates that the peptide is bound to a copper ion, normally copper(II).
The free tripeptide and its copper complex have been measured in human plasma, saliva, urine and some tissue extracts. Reported concentrations vary widely between studies, and the role of the complex in normal physiology remains partly unresolved.
The plain peptide lacks the metal, so its charge, colour and binding behaviour differ. The copper complex is blue and carries a bound copper ion, while the metal-free form is colourless and has different solution chemistry.
GHK denotes the unbound chain of three amino acids. GHK-Cu describes the form in which a copper(II) ion is held by that chain. The two are not interchangeable in solution, since charge, molecular weight, and reactivity differ.